Travelon Sold Over 1,200 Illegal “Antimicrobial” Products Before EPA Forced $100,000 Settlement

Put The Fraud In The Bag

In 2022, while the world was still processing the trauma of a global pandemic, a travel accessories company in Franklin Park, Illinois saw an opportunity. Travel Caddy, Inc., doing business as Travelon, rolled out a product line with a promise: antimicrobial protection. The bags, backpacks, pouches, and even shoe covers would fight germs. They would create a barrier. They would keep you safe.

The labels said so. The marketing said so. The product names themselves said so.

What the labels did not say is that none of it was tested. None of it was registered. And under federal law, products that claim to kill or repel microorganisms are pesticides. They require approval from the Environmental Protection Agency before a single unit can be sold.

Travelon sold 1,043 units of treated bags and pouches making unregistered pesticide claims. They sold 162 personal air purifiers that promised to remove airborne viruses without the required establishment registration number. Every single sale was a separate violation of the Federal Insecticide, Fungicide, and Rodenticide Act.

On July 23, 2026, the company signed a consent agreement with EPA Region 5. The settlement: $100,000. The docket number: FIFRA-05-2026-0015. The corporate officer who signed: Doug Brunner, Treasurer.

The bags are still out there. The purifiers are still out there. And this investigation is about what happens when corporate health theater meets regulatory failure.

The Non-Financial Ledger

This is not a story about money. This is a story about trust.

Imagine you are a parent shopping for travel gear in late 2022. You have just lived through years of fear. You have wiped down groceries. You have double-masked on airplanes. You have kept your children home from school. And now you are preparing to travel again, and a product promises “antimicrobial protection” and “intelligent technology that inhibits the spread of microorganisms.”

You pay the premium. You believe the label. You pack the bag.

What you do not know is that the company making that promise never submitted the product for safety testing. Never proved the technology worked. Never registered the pesticide claim. Never provided the EPA with toxicity data. Never disclosed what chemicals were used or at what concentration. Never demonstrated that the product would not harm your child if the treated fabric came into contact with their skin for hours on a long flight.

The EPA consent agreement does not name customers. It does not interview the families who purchased these products. It does not calculate the emotional cost of betrayal when you realize the safety you paid for was a marketing fiction.

But the violation count tells the story: 1,205 separate acts. That is 1,205 transactions. 1,205 moments where someone handed over money in exchange for a promise the company was not legally allowed to make.

“The company sold protection it never proved and safety it never tested. The regulatory system arrived four years late.”

Travelon certified in the settlement that it is now in compliance. But compliance is not restitution. The families who bought those bags in 2022 have no way to know if the “antimicrobial” treatment was effective, inert, or toxic. They have no way to know if the personal air purifier circulating ions around their necks did anything at all except drain a battery.

What they know now is that they were test subjects in an unregulated experiment conducted for profit during a public health crisis.

Legal Receipts

The consent agreement is not a trial. Travelon “neither admits nor denies the factual allegations.” But the allegations are specific, detailed, and supported by photographic evidence collected during two EPA inspections in August and September 2022.

Here is what the legal record shows, verbatim:

The document continues:

And the conclusion:

The Personal Air Purifier receives its own section. The label claimed the device was “Effective for removing airborne diseases” and would “create a health shield of clean refreshing air” by using negative ions to attach “like magnets to airborne bacteria, viruses, smoke, pollen, mites even PM 2.5 air pollutants.”

The EPA’s finding:

There is no ambiguity here. The product made pesticidal claims. The product lacked the required registration. Every sale was unlawful.

And yet the company continued distribution for years before the settlement was finalized.

Societal Impact Mapping

Public Health: The Invisible Cost

Public health protection depends on regulatory gatekeeping. When a product claims to kill or repel disease-causing organisms, federal law requires proof. This is not bureaucratic red tape. It is the mechanism that prevents snake oil from being marketed as medicine.

Travelon’s products entered the marketplace during a period of acute public health anxiety. Consumers were primed to seek out protective measures. Companies that exploited that fear with unverified claims did not just commit regulatory violations—they eroded trust in the entire system of product safety labeling.

If antimicrobial claims are unregulated, why should consumers trust any health or safety label? If a company can market a device as “effective for removing airborne diseases” without proving efficacy, what prevents the next company from claiming their bracelet cures cancer?

The consent agreement acknowledges none of this. It treats the violation as an administrative error, a paperwork problem. But the societal impact is structural: regulatory failure at scale teaches consumers that labels are meaningless.

Economic Inequality: Who Pays The Premium

Antimicrobial products are not marketed to low-income families buying discount luggage at big-box stores. They are marketed to consumers with disposable income who can afford to pay extra for perceived safety. The product line included “Origin” backpacks, “Packable” totes, and multi-piece pouch sets—items that signal lifestyle branding and premium pricing.

The economic transaction is not simply bag-for-cash. It is peace-of-mind-for-premium. The customer pays extra because they believe they are purchasing a verified health benefit. When that benefit is fraudulent, the economic harm is compounded: the customer has been charged a safety tax on a product that provided no safety.

The $100,000 fine represents approximately $83 per violation if divided across the 1,205 unlawful acts. Meanwhile, Travelon’s gross revenue from these product lines is not disclosed in the consent agreement. There is no restitution fund. There is no customer notification program. The people who paid the premium never get their money back.

Environmental Degradation: The Chemical We Don’t Track

The EPA document identifies the antimicrobial agent as “Silvadur” technology, a silver-based compound manufactured by DuPont. Silver nanoparticles are used in antimicrobial textiles because they disrupt bacterial cell walls. They are also persistent in the environment.

When antimicrobial textiles are washed, silver particles leach into wastewater. When the products reach end-of-life and are discarded, the silver enters landfills. Silver is toxic to aquatic organisms at low concentrations. Its use in consumer products is a known environmental concern.

But because Travelon never registered the products as pesticides, there was no environmental impact assessment. There was no disclosure of the concentration of silver used. There was no analysis of cumulative exposure when multiplied across 1,043 textile products sold into the consumer stream.

The EPA consent agreement is silent on environmental consequences. It is a FIFRA violation, not a Clean Water Act enforcement action. But the chemical is in the ecosystem now. The bags were washed. The purifiers were discarded. The silver particles are dispersed.

And no one tracked where they went.

The “Cost Of A Life” Metric

The math is straightforward. Travelon committed 1,205 unlawful acts and paid $100,000. That is $83 per violation.

To put that in context: a single Travelon antimicrobial backpack retails for approximately $40 to $70 depending on model. The EPA penalty per unlawful sale is higher than the product’s wholesale cost but lower than its retail price.

For a company, this is a rounding error. For a regulatory system, it is proof that the deterrent effect of enforcement has collapsed. The maximum statutory penalty under FIFRA is $24,885 per violation. EPA could have assessed over $29 million. Instead, they accepted $100,000 and a certification of current compliance.

The consent agreement notes that EPA “conducted an analysis of Respondent’s financial information and determined Respondent has a limited ability to pay.” Translation: the company claimed poverty, and the government believed them.

But financial inability to pay does not erase the harm. It simply means the cost of the violation is externalized onto the consumers who bought the products, the regulators who had to investigate, and the public that must now assume every antimicrobial claim on a travel product might be fraudulent until proven otherwise.

What Now?

The Corporate Structure That Signed The Settlement

The consent agreement was signed by Doug Brunner, Treasurer of Travel Caddy, Inc. dba Travelon. The company’s business address is listed as 11333 Addison Avenue, Franklin Park, Illinois.

The EPA complainant was Carolyn Persoon, Division Director of the Enforcement and Compliance Assurance Division, U.S. EPA Region 5. The investigating body was EPA Region 5 Pesticides and Toxics Compliance Section.

EPA legal counsel was Maria Gonzalez, Office of Regional Counsel, U.S. EPA Region 5.

The Regulatory Watchlist

The enforcement action was conducted under the authority of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), 7 U.S.C. § 136l(a). Future violations of this statute are subject to escalated penalties.

Oversight agencies with jurisdiction over similar cases include:

• Environmental Protection Agency (EPA): Pesticide product registration and enforcement
• Federal Trade Commission (FTC): False advertising and deceptive health claims
• Consumer Product Safety Commission (CPSC): Product safety labeling and chemical disclosure
• Food and Drug Administration (FDA): Claims that products prevent disease (potential jurisdiction overlap)

What You Can Do Right Now

If you purchased a Travelon antimicrobial product between 2022 and 2026, you have a record of a transaction for a product that EPA now confirms was unlawfully marketed. You are not owed restitution under this settlement, but you can:

• Document the purchase: Locate receipts, order confirmations, or product photos showing the antimicrobial claims on the label or packaging.
• File a complaint with the FTC: Deceptive health claims fall under FTC jurisdiction. Even if EPA does not pursue further enforcement, consumer protection agencies can.
• Contact your state attorney general: State-level consumer protection offices can investigate patterns of deceptive marketing and file independent actions.
• Demand transparent chemical disclosure: If you still own the product, contact the company and request full disclosure of the antimicrobial agent, its concentration, and any safety testing data. They may refuse, but the request creates a paper trail.

More broadly: Stop trusting health claims on product packaging. Assume every unverified “antimicrobial,” “antibacterial,” or “germ-fighting” label is marketing language unless the product displays an EPA registration number. If the number is missing, the claim is unregulated.

And support regulatory enforcement funding. This case took four years to resolve because EPA enforcement divisions are understaffed and underfunded. Corporate violations are cheap. Investigations are expensive. Until that equation changes, settlements like this will remain a cost-of-business bargain.